ANGELA TYUS: Open Payments
NPI 1174851745 · BAINBRIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,075 in 54 payments from 12 companies in 2025. Trend: 2023 $1,161 · 2024 $1,038 · 2025 $1,075
Food & beverage: $1,075
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $446 |
| Novo Nordisk Inc | 4 | $155 |
| Corcept Therapeutics | 3 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Exact Sciences Corporation | 2 | $40 |
| Lundbeck LLC | 2 | $39 |
| Astellas Pharma US Inc | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
Products named: VRAYLAR, Ozempic, Korlym, CAPLYTA, UBRELVY, QULIPTA, Cologuard Collection Kit, REXULTI.
Industry payments across GA — which companies pay providers there.
